Thursday , April 27 2017
Home / Resources / Videos (page 2)

Videos

We have videos from AACE, ADA, and AADE that feature the speakers from those events. You will be the first to learn about the breakthroughs in diabetes care. You will also hear about interesting research projects that our featured diabetes experts are leading.

Christophe Arbet-Engels, MD, Q10: Possibility of Combination Drugs with Empagliflozin

Dr. Christophe Arbet-Engels continues his discussion of the potential for combining the SGLT-2 inhibitor empagliflozin with other drugs down the road, and that they will certainly be exploring these otpions.  Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. See more SGLT-2 Resources

Read More »

Christophe Arbet-Engels, MD, Q11: Is Empagliflozin Also Being Submitted Internationally?

Dr. Christophe Arbet-Engels explains that Boehringer Ingelheim will also be submitting empagliflozin internationally, and certainly in the EU, and that they will also look carefully at all possibilities to submit the drug to other international authorities. Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim ...

Read More »

Christophe Arbet-Engels, MD, Q12: Diabetes Drug Efficacy in Different Populations

Dr. Christophe Arbet-Engels answer the question, “Do the Swiss get diabetes?” and, on a more serious note, explains that they are exploring different options for different patient populations to find the best treatment possible for each individual patient.   Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, ...

Read More »